Lutathera
Dutch health minister attacks Novartis over orphan drug price hike
January 15, 2019Manufacturing and Production Cancer, Lutathera, NL, Netherlands, Novartis, oncology
Dutch health minister Bruno Bairns has called for a meeting with Swiss multinational Novartis after the multibillion-dollar firm introduced a …
Radioactive drug given approval by the FDA
January 29, 2018Sales and Marketing Advanced Accelerator Applications, Lutathera, Novartis, biotech, drugs, pharma, pharmaceutical
The FDA has approved Lutathera, marking the first time that the agency has given approval for a radioactive drug or …
Novartis to bolster oncology portfolio with $3.9 billion acquisition
October 30, 2017Sales and Marketing Advanced Acclerator Applications, Lutathera, Novartis, pharma
Novartis has announced its intention to acquire France’s Advanced Accelerator Applications (AAA) for $3.9 billion in a move to reinforce …
Latest content
Global coalition calls for stronger government action on COPD
September 18, 2026
Global health researchers call for more equitable partnerships
September 17, 2026
Liverpool launches £20m lab for infectious disease drug discovery
September 16, 2026
Circle Health Group expands into UK laboratory operations
September 15, 2026
